SCHEMBL353281

SCHEMBL353281

CN(Cc1csc(NC(=O)NCc2ccc(Cl)s2)n1)C(=O)C1(c2ccccc2)CCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.43
EP300 Q09472 1/20 0.37
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
ROCK2 O75116 3/20 0.36
ROCK1 Q13464 3/20 0.36
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
ELOVL1 Q9BW60 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SCD O00767 3/20 0.35
LMNA P02545 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL354784 0.90 ROCK2 (0.39) HSD11B1ROCK2ROCK1RAB9ALMNA
SCHEMBL352911 0.87 HSD11B1 (0.42) HSD11B1EP300NCOA1NCOA3ROCK2
SCHEMBL353459 0.86 KMT2A (0.38) ROCK2ROCK1MEN1KMT2ANPC1
SCHEMBL19119207 0.82 MEN1 (0.38) ROCK2ROCK1MEN1KMT2ANPC1
SCHEMBL354067 0.81 F10 (0.38) ROCK2ROCK1MEN1KMT2ANPC1
SCHEMBL353072 0.81 ROCK2 (0.51) ROCK2ROCK1
SCHEMBL353479 0.80 SCD (0.39) ROCK2ROCK1MEN1KMT2ANPC1
SCHEMBL352895 0.80 SMN1; SMN2 (0.39) ROCK2ROCK1MEN1KMT2ANPC1
SCHEMBL354863 0.79 KMT2A (0.39) ROCK2ROCK1MEN1KMT2ANPC1
SCHEMBL352887 0.79 HSD11B1 (0.41) HSD11B1ROCK2ROCK1KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US claimed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US claimed
US-8148380-B2 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds CRESTONE, INC. (US) 2012-04-03 US disclosed
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds CRESTONE, INC. (US) 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120015941-A1 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds NAAA, AADAC, RPSA HSD11B1 4561/4885EP300 932/4885NCOA1 1302/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.